NeoTract, a wholly owned subsidiary of Teleflex Incorporated focused on addressing unmet needs in the field of urology, today announced the results of an independent analysis measuring costs and patient outcomes of the UroLift System compared to transurethral resection of the prostate. NeoTract announces results of study measuring costs and patient outcomes of UroLift System
Aucun commentaire:
Enregistrer un commentaire